- Home
- EVOK vs OMH Comparison
EVOK vs OMH Comparison
Compare EVOK & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVOK | OMH |
|---|---|---|
| Founded | 2007 | 2015 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.4M | 17.6M |
| IPO Year | 2013 | 2023 |
Fundamental Metrics
Financial Performance| Metric | EVOK | OMH |
|---|---|---|
| Price | $10.98 | $0.89 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 30.4K | ★ 178.3K |
| Earning Date | 11-13-2025 | 04-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,424,652.00 | $10,264,748.00 |
| Revenue This Year | $58.96 | $28.40 |
| Revenue Next Year | $57.99 | $23.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 67.40 | ★ 78.86 |
| 52 Week Low | $1.94 | $0.59 |
| 52 Week High | $10.99 | $5.10 |
Technical Indicators
Market Signals| Indicator | EVOK | OMH |
|---|---|---|
| Relative Strength Index (RSI) | 85.18 | 43.41 |
| Support Level | $10.66 | $0.79 |
| Resistance Level | $10.99 | $1.15 |
| Average True Range (ATR) | 0.04 | 0.07 |
| MACD | -0.18 | 0.03 |
| Stochastic Oscillator | 95.00 | 25.41 |
Price Performance
Historical ComparisonAbout EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.
About OMH Ohmyhome Limited
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.